Regeneron (REGN) Tops Q2 EPS by 17c; Updates FY16 Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Regeneron Reports Second Quarter 2016 Financial and Operating Results
August 4, 2016 6:30 AM EDTTARRYTOWN, N.Y., Aug. 4, 2016 /PRNewswire/ --Â Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)Â today announced financial results for the second quarter of 2016 and provided a business update.
Financial Highlights
($ in millions, except per share data)
Three Months... More
